Summit Securities Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-100
Closed -$5K – 949
2022
Q2
$5K Buy
+100
New +$5.68K ﹤0.01% 867
2022
Q1
– Sell
-5,900
Closed -$304K – 1125
2021
Q4
$304K Buy
+5,900
New +$289K 0.01% 492
2019
Q4
– Sell
-180
Closed -$849K – 436
2019
Q3
$849K Buy
+180
New +$8.22K 0.08% 147

Other funds holding CAH

Summit Securities Group's CAH Position: Q3 2026 in Review

Summit Securities Group increased its Cardinal Health (CAH) stake by 411% in Q3 2026, buying an estimated $368K and bringing the position to 1,969 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #196.

Summit Securities Group first reported a position in CAH in Q4 2013 and has held it in 25 quarters since. The position peaked at $698K in Q4 2024. 1,491 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Summit Securities Group held 1,969 shares of Cardinal Health worth $438K as of Q3 2026.
  • Summit Securities Group bought 1,584 Cardinal Health shares in Q3 2026, an estimated $368K.
  • Cardinal Health made up 0.04% of Summit Securities Group's portfolio in Q3 2026, its #196 holding.
  • Summit Securities Group first reported a position in Cardinal Health in Q4 2013 and has held it in 25 quarters since.
  • Summit Securities Group's Cardinal Health position peaked at $698K in Q4 2024.
  • 1,491 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.